Skip to main content
OpenTrials
Recruiting

NCT Number: NCT03732612

Inflammation in Vascular Disease

Increasing evidence suggests that systemic low-grade inflammation may be a driving force of cardiometabolic complications, such as vascular dysfunction, atherosclerosis and ischemic heart disease. Thus, we will investigate the role of inflammation in cardiovascular disease.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

University of Gothenburg

Gothenburg, Vastragotaland, 40530, Sweden

Location status: Recruiting

Location contact

Emma Borgeson, PhD

CONTACT

+4631342000

Per Skoog, MD, PhD

CONTACT

+4631342000

About this study

Vascular reconstruction surgeries usually require a small piece of the vessel wall to be excised. The excised vessel is generally discarded as medical waste: however, for patients participating in the study, the excised tissue will be placed in saline and collected for research use.

Tissue collected from individuals undergoing vascular surgery associated with peripheral arterial diseases, aneurysm and/or other manifestations of atherosclerosis, vascular tissue will be cultured ex vivo in the presence or absence of therapeutic agents, to determine if these attenuate the inflammation associated with the atherosclerotic phenotype. Furthermore, the protocol will also be carried out using vascular tissue from control patients, which have undergone vascular surgery that is not associated with vascular disease (e.g. knee replacement surgery, trauma, etc).

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patient is planned to undergo vascular surgery.
  • Signed informed consent has been obtained from the patient.

Exclusion criteria

  • Patient has difficulty to understand information.
  • Patients under 18 years of age.
  • Patients participating in any drug-related study.

Treatment and study plan

Primary outcomes

  1. Inflammatory status

    Time frame: 2019-2024

    The inflammatory status will be studied in patients with atherosclerotic disease.

Study contacts

Contact information is provided by the study sponsor or research team.

Emma Borgeson, PhD

CONTACT

[email protected]

+46313420000

Per Skoog, MD, PhD

CONTACT

[email protected]

+46313420000

Sponsors and collaborators

Lead sponsor

Göteborg University

Other

Registry information

Official study title

The Role of Inflammation in Vascular Disease (Inflammationens Roll i kärlsjukdom)

Acronym: REBEL

Important dates

Study start
2019
Primary completion
2026
Study completion
2027
First posted
Nov 6, 2018
Registry last updated
May 6, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.